Monocyte count result
|
phenotype |
|
Laboratory or Test Result
|
139
|
296
|
0.100 |
None |
1.000 |
4 |
3
|
2013 |
2018 |
Monocyte count procedure
|
phenotype |
|
Laboratory Procedure
|
139
|
296
|
0.100 |
None |
1.000 |
4 |
3
|
2013 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.040 |
None |
1.000 |
4 |
|
2008 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.030 |
None |
1.000 |
3 |
1
|
2013 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.030 |
None |
1.000 |
3 |
1
|
2013 |
2019 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1308
|
705
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2018 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2019 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.020 |
None |
1.000 |
2 |
1
|
2013 |
2018 |
Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
391
|
7
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2016 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2016 |
Chemokine (C-C Motif) Ligand 19 Measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
2
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hepatitis C, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
430
|
80
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Corneal graft rejection
|
disease |
Eye Diseases
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Köbner phenomenon
|
disease |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Psoriasiform eczema
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
62
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1453
|
144
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Protein measurement
|
group |
|
Laboratory Procedure
|
75
|
422
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Arthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
1072
|
69
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Immune-complex glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |